Skip to main content
Log in

99mTc-MAG3, a new renal imaging agent: Preliminary results in patients

  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

99mTc-mercaptoacetyltriglycine (MAG3) is a new renal radiopharmaceutical which has been shown to have biological properties similar to131I-hippurate (OIH) in animals and volunteers.99mTc-MAG3 has now been compared with131I-orthoiodohippurate (OIH) in a group of patients with varying degrees of renal impairment. In all cases, the99mTc-MAG3 images were superior regardless of serum creatinine. Selected examples are illustrated including scans and renogram curves in a normal volunteer, transplant patients with creatinines of 9.8 mg/dl and 2.6 mg/dl respectively, and a furosemide study in a patient with questionable obstruction. Our preliminary results suggest that99mTc-MAG3 performs well in patients with impaired renal function and may well provide an acceptable replacement for OIH. A kit formulation has been developed and will soon be undergoing clinical evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Barbour GL, Crumm CK, Boyd CM, (1976) Comparison of inulin, iothalamate, and99mtechnetium DTPA for measurement of glomerular filtration rate. J Nucl Med 17:317–320

    Google Scholar 

  • Blaufox MD, Potchen EJ, Merrill JP (1967) Measurement of effective renal plasma flow in man by external counting methods. J Nucl Med 8:77–85

    Google Scholar 

  • Chervu RL, Sundoro BM, Blaufox MD (1984) Technetium-99m labeled p-aminohippuric acid analog: a new renal agent: Concise communication. J Nucl Med 25:1111–1115

    Google Scholar 

  • Davison A, Jones A, Orvig C, Sohn M (1981) A new class of oxotechnetium (+5) chelate complexes containing a TcON2S2 core. Inorg Chem 20:1629–1632

    Google Scholar 

  • Fritzberg AR, Kasina S, Eshima D (1986) Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J Nucl Med 27:111–116

    Google Scholar 

  • Fritzberg AR, Klingensmith WS, Whitney WP, Kuni CC (1981) Chemical and biological studies of Tc-99m N, N′-bis(mercaptoacetamido)-ethylenediamine: A potential replacement for I-131 hippuran. J Nucl Med 22:258–263

    Google Scholar 

  • Fritzberg AR, Kuni CC, Klingensmith WC, (1982) Synthesis and biological evaluation of Tc-99m N, N′-bis(mercaptoacetyl)-2,3-diaminopropanoate A potential replacement for (I-131)-o-iodohippurate. J Nucl Med 23:592–598

    Google Scholar 

  • Klingensmith WC, Fritzberg AR, Spitzer VM, (1983) Clinical evaluation of Tc-99m N,N′-bis(mercaptoacetyl)-2 3-diaminopropanoate as a replacement for I-131 hippuran. J Nucl Med 24: P 80

    Google Scholar 

  • Klingensmith WC III, Gerhold JP, Fritzberg AR, (1982) Clinical comparison of TC-99m N,N′-bis(mercaptoacetamido)-ethyl-enediamine and [131I] ortho-iodohippurate for evaluation of renal tubular function: Concise communication. J Nucl Med 23:377–380

    Google Scholar 

  • Klopper JF, Hauser W, Atkins HL, (1972) Evaluation of99mTc-DTPA for the measurement of glomerular filtration rate. J Nucl Med 8:77–85

    Google Scholar 

  • Marcus CS, Kuperus JH (1985) Pediatric Renal I-123 Orthoiodo-hippurate dosimetry. J Nucl Med 26:1211–1214

    Google Scholar 

  • McAfee JG, Grossman ZD, Gagne GR, (1981) Comparison of renal extraction efficiencies for radioactive agents in the normal dog. J Nucl Med 22:333–338

    Google Scholar 

  • Sapirstein LA, Vidt D, Mandel M (1955) Volumes of distribution and clearances of intravenously injected creatinine in the dog. Am J Physiol 181:330

    Google Scholar 

  • Stadalnik RC, Vogel JM, Jansholt A-L, Krohn KA, Matolo NM, Lagunas-Solar MC, Zielinski FW (1980) Renal clearance and extraction parameters of ortho-iodohippurate (I-123) compared with OIH (I-131) and PAH. J Nucl Med 21:168–170

    Google Scholar 

  • Taylor AT (1980) Quantitative renal function scanning: A historical and current status report on renal radiopharmaceuticals. In: Freeman LM, Weissman HS (eds) Nuclear Medicine Annual 1980. Raven Press, New York, pp 303–340

    Google Scholar 

  • Taylor A, Eshima D, Christian PC (1986a) Comparison of Tc-99m mercaptoacetyltriglycine (MAG3) and OIH in normal subjects and patients. J Nucl Med 27:962 (abstr)

    Google Scholar 

  • Taylor A, Eshima D, Fritzberg AR, (1986b) Comparison of I-131 OIH and Tc-99m MAG3 renal imaging in volunteers. J Nucl Med 27:795–803

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, A., Eshima, D. & Alazraki, N. 99mTc-MAG3, a new renal imaging agent: Preliminary results in patients. Eur J Nucl Med 12, 510–514 (1987). https://doi.org/10.1007/BF00620476

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00620476

Key words

Navigation